BACKGROUND: This retrospective study describes the epidemiology of small bowel carcinoids in a geographically defined population, with no other selection bias. METHODS: All patients (n = 145) resident in Jönköping County when diagnosed with carcinoid in the jejunum or ileum from 1960 to 2005 were included. Medical records were reviewed in detail, and tumor specimens were histopathologically and immunohistochemically reexamined when required (n = 44). RESULTS: The annual age-adjusted incidence of small bowel carcinoids was 1.12 (95% confidence interval 0.95-1.31) per 100,000 persons. Median age at diagnosis was 69 years. The predominating presenting symptom was uncharacteristic abdominal pain (50%), whereas a smaller number suffered from typical flushes (13%). Surprisingly, 14% presented with overt gastrointestinal hemorrhage. Most of the patients diagnosed based on their symptoms had metastases at diagnosis (44% regional, 40% distant). Metastasized tumors by definition belong to World Health Organization (WHO) histopathologic group 2; and when reexamined, most (83%) of the localized tumors were also found to belong to WHO group 2. CONCLUSIONS: In comparison to previous reports, a higher age-adjusted incidence of small bowel carcinoids was observed, and the patients were clearly older at the time of diagnosis. Even with metastatic disease, the presenting symptoms were usually uncharacteristic, and the carcinoid syndrome was infrequently seen.
BACKGROUND: This retrospective study describes the epidemiology of small bowel carcinoids in a geographically defined population, with no other selection bias. METHODS: All patients (n = 145) resident in Jönköping County when diagnosed with carcinoid in the jejunum or ileum from 1960 to 2005 were included. Medical records were reviewed in detail, and tumor specimens were histopathologically and immunohistochemically reexamined when required (n = 44). RESULTS: The annual age-adjusted incidence of small bowel carcinoids was 1.12 (95% confidence interval 0.95-1.31) per 100,000 persons. Median age at diagnosis was 69 years. The predominating presenting symptom was uncharacteristic abdominal pain (50%), whereas a smaller number suffered from typical flushes (13%). Surprisingly, 14% presented with overt gastrointestinal hemorrhage. Most of the patients diagnosed based on their symptoms had metastases at diagnosis (44% regional, 40% distant). Metastasized tumors by definition belong to World Health Organization (WHO) histopathologic group 2; and when reexamined, most (83%) of the localized tumors were also found to belong to WHO group 2. CONCLUSIONS: In comparison to previous reports, a higher age-adjusted incidence of small bowel carcinoids was observed, and the patients were clearly older at the time of diagnosis. Even with metastatic disease, the presenting symptoms were usually uncharacteristic, and the carcinoid syndrome was infrequently seen.
Authors: James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans Journal: J Clin Oncol Date: 2008-06-20 Impact factor: 44.544
Authors: Eduardo A Perez; Leonidas G Koniaris; Sarah E Snell; Juan C Gutierrez; William E Sumner; David J Lee; Nicole C Hodgson; Alan S Livingstone; Dido Franceschi Journal: World J Surg Date: 2007-05 Impact factor: 3.352
Authors: Ignat Drozdov; Mark Kidd; Boaz Nadler; Robert L Camp; Shrikant M Mane; Oyvind Hauso; Bjorn I Gustafsson; Irvin M Modlin Journal: Cancer Date: 2009-04-15 Impact factor: 6.860
Authors: Daniel M Halperin; Chan Shen; Arvind Dasari; Ying Xu; Yiyi Chu; Shouhao Zhou; Ya-Chen Tina Shih; James C Yao Journal: Lancet Oncol Date: 2017-02-24 Impact factor: 41.316
Authors: Chiara De Divitiis; Claudia von Arx; Roberto Carbone; Fabiana Tatangelo; Elena Di Girolamo; Giovanni Maria Romano; Alessandro Ottaiano; Elisabetta de Lutio di Castelguidone; Rosario Vincenzo Iaffaioli; Salvatore Tafuto Journal: Onco Targets Ther Date: 2015-03-31 Impact factor: 4.147
Authors: Heba Alwan; Stefano La Rosa; Peter Andreas Kopp; Simon Germann; Manuela Maspoli-Conconi; Christine Sempoux; Jean-Luc Bulliard Journal: Cancer Med Date: 2020-10-20 Impact factor: 4.452